NCT07808632

Brief Summary

This randomized controlled trial aims to evaluate the effects of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters. A total of 34 patients will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. Participants in the intervention group will use a stress ball during femoral arterial sheath removal in addition to routine care, while participants in the control group will receive routine care only. Pain, anxiety, patient satisfaction, and hemodynamic parameters will be assessed before and at specified time points after femoral arterial sheath removal.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
9mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Sep 2026Jun 2027

First Submitted

Initial submission to the registry

September 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 9, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

September 10, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

September 9, 2026

Status Verified

September 1, 2026

Enrollment Period

10 months

First QC Date

September 2, 2026

Last Update Submit

September 2, 2026

Conditions

Keywords

Femoral Arterial Sheath RemovalStress BallPainAnxietyPatient SatisfactionHemodynamic Parameters

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst possible pain). Higher scores indicate greater pain intensity.

    Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

Secondary Outcomes (7)

  • Anxiety Level

    Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  • Patient Satisfaction

    Immediately before femoral arterial sheath removal and 30 minutes after removal.

  • Systolic Blood Pressure

    Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  • Diastolic Blood Pressure

    Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  • Heart Rate

    Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  • +2 more secondary outcomes

Study Arms (2)

Stress Ball Group

EXPERIMENTAL

Participants in this group will use a stress ball in addition to routine care. The stress ball intervention will begin approximately one minute before femoral arterial sheath removal and will continue during and after sheath removal for a total of 10 minutes.

Behavioral: Stress Ball

Control Group

NO INTERVENTION

Participants in this group will receive routine care only, without any additional nonpharmacological intervention.

Interventions

Stress BallBEHAVIORAL

Participants will be given a round, medium-firm silicone stress ball approximately 6 cm in diameter. They will be instructed to hold the stress ball in the palm of their hand and rhythmically squeeze and release it after counting to three. The intervention will begin approximately one minute before femoral arterial sheath removal and will continue during and after sheath removal for a total of 10 minutes. Routine clinical care will continue throughout the intervention.

Stress Ball Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent coronary angiography via the femoral artery and received stent implantation or balloon angioplasty
  • Aged 18 years or older
  • Willing to participate in the study and providing written informed consent
  • Conscious, oriented, and cooperative
  • Able to read and understand Turkish
  • No hearing or visual impairment that would interfere with participation
  • Clinically and hemodynamically stable
  • No diagnosed psychiatric disorder

You may not qualify if:

  • Coronary angiography performed via the radial artery
  • Development of a complication during coronary angiography, such as arrhythmia
  • Administration of sedation during coronary angiography
  • Pregnancy
  • Prisoners or other vulnerable individuals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Turkey, Mersin University Hospital

Yenişehir, Mersin, 33120, Turkey (Türkiye)

Location

Related Publications (2)

  • Akcoban S, Tosun B, Yuksel H. The Effect of Stress Ball Use on Immobilization Comfort, Pain Level, and Vital Signs in Patients After Coronary Angiography. J Cardiovasc Nurs. 2026 Jan-Feb 01;41(1):E25-E32. doi: 10.1097/JCN.0000000000001202. Epub 2025 Apr 9.

    PMID: 40198758BACKGROUND
  • Yuksel D, Gunes D. The Effect of Stress Ball on Anxiety and Pain Levels in Angiography: A Randomized Controlled Trial. Cardiovasc Ther. 2024 Aug 24;2024:5049092. doi: 10.1155/2024/5049092. eCollection 2024.

    PMID: 39742013BACKGROUND

MeSH Terms

Conditions

PainAnxiety DisordersPatient Satisfaction

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Tuğba ÇAM YANIK

    Mersin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tuğba ÇAM YANIK, PHD

CONTACT

TUGBA ÇAM YANIK, PHD, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, participants and the researcher administering the intervention cannot be blinded. Data will be coded as Group A and Group B, and the statistical analysis will be performed by an independent statistician who is blinded to group allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Surgical Diseases Nursing

Study Record Dates

First Submitted

September 2, 2026

First Posted

September 9, 2026

Study Start

September 10, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

September 9, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to participant confidentiality and data protection considerations. Aggregate study findings will be reported in scientific publications.

Locations